Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

16.84

+0.41 (2.50%)

Aug 7, 2026, 4:00 PM EDT - Market closed

Crescent Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	171.59	213.19	34.77	41.79	47.87	90.25
Cash & Short-Term Investments	171.59	213.19	34.77	41.79	47.87	90.25
Cash Growth	12.41%	513.22%	-16.81%	-12.70%	-46.96%	-34.14%
Accounts Receivable	-	18	-	-	-	-
Other Current Assets	7.52	5.57	0.04	2	2.84	0.53
Total Current Assets	179.01	236.66	34.8	43.79	50.71	90.79
Net Property, Plant & Equipment	2.15	2.32	-	0.77	0.75	1.95
Other Long-Term Assets	1.5	1.22	0.81	0.76	0.34	1.61
Total Assets	182.76	240.29	35.62	45.32	51.81	94.35

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.54	10.14	7.33	0.87	0.97	2.11
Accrued Expenses	7.41	16.34	2.23	5.23	6.99	8.72
Current Portion of Leases	0.47	0.44	-	0.74	0.92	1
Unearned Revenue	3.12	4.16	-	-	-	-
Other Current Liabilities	5	5	0.06	-	-	-
Total Current Liabilities	18.54	36.07	9.61	6.84	8.88	11.82
Long-Term Debt	-	-	37.48	-	-	-
Long-Term Leases	0.97	1.21	-	-	-	-
Total Long-Term Liabilities	0.97	1.21	37.48	-	-	-
Total Liabilities	19.5	37.28	47.1	6.9	8.88	12.74

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Preferred Stock	4	4	-	-	-	-
Common Stock	0.03	0.03	0	-	-	-
Total Common Shareholders' Equity	4.03	4.03	0	-	-	-
Minority Interest	-	-	4	-	-	-
Shareholders' Equity	159.23	198.98	-15.48	38.41	42.88	81.55
Total Liabilities & Equity	182.76	240.29	35.62	45.32	51.81	94.35

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.44	1.64	37.48	0.74	0.92	1
Net Cash (Debt)	170.16	211.55	-2.72	41.05	46.95	89.25
Net Cash Growth	11.63%	-	-	-12.57%	-47.39%	-34.44%
Net Cash Per Share	6.97	20.31	-4.21	64.81	89.38	173.47
Book Value	4.03	4.03	0	0	0	0
Book Value Per Share	0.17	0.39	0.00	-	-	-
Tangible Book Value	4.03	4.03	0	0	0	0
Tangible Book Value Per Share	0.17	0.39	0.00	-	-	-

SEC Filings: 10-K · 10-Q